All Stories

  1. Safety And Efficacy Of The Unique Opioid Buprenorphine For The Treatment Of Chronic Pain

    Article • Journal of Pain Research, December 2019, Taylor & Francis

    Robert Raffa

  2. Designing safer analgesics: a focus on μ-opioid receptor pathways

    Article • Expert Opinion on Drug Discovery, September 2018, Taylor & Francis

    Robert Raffa, Daniel Colucci

  3. Going beyond prescription pain relievers to understand the opioid epidemic: the role of illicit fentanyl, new psychoactive substances, and street heroin

    Article • Postgraduate Medicine, November 2017, Taylor & Francis

    Robert Raffa

  4. Revisiting transdermal scopolamine for postoperative nausea and vomiting

    Article • Research and Reports in Transdermal Drug Delivery, August 2015, Dove Medical Press

    Robert Raffa

  5. Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease

    Article • Journal of Pain Research, May 2015, Dove Medical Press

    Professor Consalvo Mattia, Robert Raffa

  6. The unsolved case of “bone-impairing analgesics”: the endocrine effects of opioids on bone metabolism

    Article • Therapeutics and Clinical Risk Management, March 2015, Dove Medical Press

    Professor Consalvo Mattia, Robert Raffa

  7. Fixed-dose combinations at the front line of multimodal pain management: perspective of the nurse-prescriber

    Article • Nursing Research and Reviews, February 2013, Taylor & Francis

    Robert Raffa

  8. Tramadol/paracetamol fixed-dose combination in the treatment of moderate to severe pain

    Article • Journal of Pain Research, August 2012, Taylor & Francis

    Robert Raffa

  9. Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literature

    Article • Journal of Pain Research, April 2012, Taylor & Francis

    Dr Robert Taylor, Robert Raffa